U.K. universities and Pfizer to collaborate on orphan drug development

05/11/2014 | Reuters

Pfizer and six British universities, including Cambridge and Oxford, have reached an agreement to collaborate in the search for drugs to treat diseases affecting less than 0.1% of the population. More than 6,000 such rare diseases are recognized worldwide, and the majority are thought to be gene-based.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX